Clinical Therapeutics

The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies
pp. 1019-1034(16)
Authors: Zanella M.-T.; Ribeiro A.B.

Efficacy of budesonide in inhaled corticosteroid-naive patients and patients with mild persistent asthma
pp. 1035-1048(14)
Author: Eigen H.

A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension
pp. 1049-1061(13)
Authors: Gradman A.H.; Brady W.E.; Gazdick L.P.; Lyle P.; Zeldin R.K.

The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers
pp. 1062-1071(10)
Authors: Miller A.K.; DiCicco R.A.; Freed M.I.

A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain
pp. 1072-1089(18)
Authors: Black P.; Max M.B.; Desjardins P.; Norwood T.; Ardia A.; Pallotta T.

Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing
pp. 1090-1104(15)
Authors: Burgess D.S.; Waldrep T.

Efficacy and tolerability of a ''suprabioavailable'' formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials
pp. 1105-1116(12)
Authors: Ramjattan B.R.; Callaghan D.J.G.; Theiss U.

A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris
pp. 1117-1133(17)
Authors: Cunliffe W.J.; Holland K.T.; Bojar R.; Levy S.F.

Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections
pp. 1134-1147(14)
Authors: Bucko A.D.; Hunt B.J.; Kidd S.L.; Hom R.

Double-blind, placebo-controlled, dose-ranging study of ramosetron for the prevention of nausea and vomiting after thyroidectomy
pp. 1148-1153(6)
Authors: Fujii Y.; Tanaka H.

A retrospective assessment of the effectiveness of fenofibrate 267 mg on high-density lipoprotein cholesterol levels in patients attending a lipid clinic
pp. 1154-1160(7)
Authors: le Roux C.W.; Murphy E.; Seed M.

Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge
pp. 1161-1174(14)
Authors: Lanier B.Q.; Abelson M.B.; Berger W.E.; Granet D.B.; D'Arienzo P.A.; Spangler D.L.; Kagi M.K.

Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study
pp. 1175-1193(19)
Authors: Ludwig M.; Stapff M.; Ribeiro A.; Fritschka E.; Tholl U.; Smith R.D.; Stumpe K.O.

Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study
pp. 1194-1200(7)
Author: Kaplan E.M.

The pharmaceutical market: Informing the debate
pp. 1202-1203(2)
Author: Coons S.J.

Pharmaceutical patents and price controls
pp. 1204-1222(19)
Author: Vogel R.J.

Correction
pp. 1223-1224(2)